Successful embryo implantation requires a synchronized dialogue between a competent blastocyst and the receptive endometrium, which occurs in a limited time period known as the ''window of implantation.'' Recent studies suggested that down-regulation of olfactomedin 1 (OLFM1) in the endometrium and fallopian tube is associated with receptive endometrium and tubal ectopic pregnancy in humans. Interestingly, the human chorionic gonadotropin (hCG) induces miR-212 expression, which modulates OLFM1 and C-terminal binding protein 1 (CTBP1) expressions in mouse granulosa cells. Therefore, we hypothesized that embryo-derived hCG would increase miR-212 expression and down-regulate OLFM1 and CTBP1 expressions to favor embryo attachment onto the female reproductive tract. We found that hCG stimulated the expression of miR-212 and down-regulated OLFM1 but not CTBP1 mRNA in both human endometrial (Ishikawa) and fallopian (OE-E6/E7) epithelial cells. However, hCG suppressed the expression of OLFM1 and CTBP1 proteins in both cell lines. The 3 0 UTR of both OLFM1 and CTBP1 contained binding sites for miR-212. The miR-212 precursor suppressed luciferase expression, whereas the miR-212 inhibitor stimulated luciferase expression of the wild-type (WT)-OLFM1 and WT-CTBP1 reporter constructs. Furthermore, hCG (25 IU/ml) treatments stimulated trophoblastic (Jeg-3) spheroid (blastocyst surrogate) attachment onto Ishikawa and OE-E6/E7 cells. Transfection of miR-212 precursor increased Jeg-3 spheroid attachment onto Ishikawa cells and decreased OLFM1 and CTBP1 protein expressions, whereas the opposite occurred with miR-212 inhibitor. Taken together, hCG stimulated miR-212, which in turn down-regulated OLFM1 and CTBP1 expression in fallopian and endometrial epithelial cells to favor spheroid attachment.
INTRODUCTION
Approximately 75% of cases of infertility are due to the failure to conceive or implant in humans [1] . Competent embryos can only implant onto a receptive endometrium within a limited time period called the ''window of implantation'' (WOI) between Days 19 and 24 of the menstrual cycle [2] . An ectopic pregnancy can occur if the embryo implants in the fallopian tube instead of the uterus wall. How the embryo-maternal interactions regulate these processes remains largely unknown [3] . The preimplantation embryo secretes human chorionic gonadotropin (hCG) as early as the two-cell stage. The secreted hCG binds to luteinizing hormone/hCG receptors (LHCGRs) on endometrial cells, which then modulates the endometrial microenvironment necessary for implantation [4] .
MicroRNAs in eukaryotes are small noncoding endogenous RNA molecules about 21-22 nucleotides long [5, 6] . More than 30% of the human genome is regulated by miRNAs [6] . MicroRNAs are also present in other body fluids such as plasma, serum, and saliva. Hence, circulating miRNAs can regulate the expressions of target proteins located far away [7] [8] [9] . MicroRNAs exert their regulatory functions posttranscriptionally by base pairing with mRNAs in the cytoplasm [6] . In humans, miRNAs can regulate diverse biological functions, including hematopoietic cell differentiation, apoptosis, cell proliferation, organ development [10] , metabolism [11] , and embryo formation, development [12] , and implantation [13] .
Human chorionic gonadotropin has been reported to modulate miR-212 and miR-132 expressions in mural granulosa cells in vivo [14] . The gene coding for miR-212 is located on chromosomes 17, 11, and 10 in humans, mice, and rats, respectively [15, 16] . Dysregulation of miR-212 expression has been associated with lung cancer and neuronal disorders [16, 17] . Moreover, miR-212 has been found to be an important regulator in bovine embryogenesis [18] . Results from previous studies have suggested that LH/hCG induces miR-212, resulting in repressed expressions of C-terminal binding protein 1 (Ctbp1) [14] and olfactomedin 1 (Olfm1) [19] in mouse ovarian tissue.
C-terminal binding protein (CTBP) is a class of proteins known as non-DNA-binding transcriptional regulators [20] . Its members are involved in numerous developmental and biological pathways, including the canonical Wnt and BMP/TGFb-signaling, cell-cell adhesion, apoptosis, myogenesis, and vascularization [21, 22] . Two proteins in the Ctbp family, Ctbp1 and Ctbp2, were found to be important in transcriptional regulation during mouse development [23, 24] . Although CTBP1 was found in both nucleus and cytoplasm, CTBP2 expression was restricted to the nucleus because of presence of a unique 20-amino-acid N-terminal domain (NTR) [25] . Mice without Ctbp1 were viable but had a reduced lifespan, whereas Ctbp2-null mice had developmental defects and were nonviable [24, 26] . A recent study identified CTBP1 antisense as a factor in the regulation of polycystic ovary syndrome in Chinese women [27] and prostate cancer development [28] .
Olfactomedin 1 is a member of the family of olfactomedin domain-containing proteins. It is a 57-kDa secretory glycoprotein mainly found in the extracellular matrix [29, 30] . A recent study reported that secreted Olfm1 regulated neuronal growth in mice via the Nogo A receptor complex [31] . We previously reported that OLFM1 transcripts were down-regulated in the secretory endometrium during the WOI when compared to the proliferative phase. Furthermore, the endometrial epithelial cell line (Ishikawa) treated with recombinant OLFM1 protein resulted in the suppression of choriocarcinoma (JAr) spheroid attachment onto the monolayer of Ishikawa cells. This suggests an overexpression of the OLFM1 protein might impair early embryo attachment onto the receptive endometrium, whereas reduced OLFM1 expression in the receptive endometrium might favor attachment [32] .
In silico analysis identified miR-212 complementary sequences in the 3 0 UTR of OLFM1 and CTBP1 [33] . We hypothesized that hCG down-regulates OLFM1 and CTBP1 through miR-212 in human fallopian tube epithelial cells and endometrial epithelial cells to enhance embryo attachment. In this study, we used human fallopian tube epithelial cells (OE-E6/E7) and human endometrial adenocarcinoma cells (Ishikawa) to study trophoblast spheroids (blastocyst surrogate) attachment to simulate early embryo implantation by mimicking the early stage of attachment at ectopic and eutopic sites, respectively [34, 35] . We further investigated the roles of hCG and miR-212 on regulating OLFM1 and CTBP1 expressions and whether this affected spheroid attachment.
MATERIALS AND METHODS

Cell Lines
Human endometrial adenocarcinoma Ishikawa cells (ECACC, 99040201), human fallopian tube epithelial OE-E6/E7 cells [36] , human choriocarcinoma Jeg-3 cells (ATCC, HTB-36), and human cervical adenocarcinoma HeLa cells (ATCC, CRM-CCL-2) were cultured in a humid environment at 378C and 5% CO 2 . OE-E6/E7, Jeg-3, and HeLa cells were maintained in Dulbecco modified Eagle medium (DMEM)/F12 medium; Sigma) supplemented with 10% fetal bovine serum (FBS; Gibco), 2 mM L-glutamine (Gibco), 100 U/ml penicillin, and 0.1 mg/ml streptomycin (Gibco). Ishikawa cells were maintained in minimal essential medium (MEM; Sigma) supplemented with FBS, L-glutamine, and penicillin/streptomycin as above. 
Quantitative PCR
Total RNA were extracted using the mirVana PARIS kit (Applied Biosystems) according to the manufacturer's instructions. The RNA integrity and concentrations were determined using a NanoDrop 2000/2000c Spectrophotometer (Thermo Scientific). Total RNA (1 lg) was reverse transcribed using TaqMan RT reagents (ABI Biosystems) for mRNA quantitation. The miRNAs (100 ng) were reverse transcribed using the TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems). All quantitative PCR experiments were performed using the Applied Biosystems 7500 Detection System (Applied Biosystems) according to standard protocols for miRNA and mRNA. The relative expressions of miRNA and mRNA were quantified using the 2
ÀDDct method, were normalized with human miR-16 (hsa-miR-16) and human 18S ribosomal RNA, respectively, and followed the MIQE guidelines [37] . The miR-212 (hsa-miR-212, RT-000515, and TM-000515), miR-16 (hsamiR-16, RT-000391, and TM-000391), OLFM1 (Hs000255159_m1), CTBP1 (Hs00972284_m1), and 18S (4319413E) TaqMan probes were all purchased from Applied Biosystems.
Western Blotting
Ishikawa and OE-E6/E7 cells were lysed in radioimmunoprecipitation assay buffer (13 PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, and 0.1% SDS) with protease inhibitors (Calbiochem). Protein concentrations were measured by the Bradford assay. Protein loading was normalized for Western blotting for the detection of human OLFM1 and CTBP1 proteins. Forty micrograms of protein was loaded into each well. The primary antibodies were rabbit polyclonal antibodies against OLFM1 (1:1000 dilution; product no. ab71540; Abcam) and affinity-purified goat polyclonal antibodies against a peptide mapped to the CTBP1 (1:1000 dilution; product no. SC-5963; Santa Cruz). Membranes were reprobed with b-actin antibody (1:20 000 dilution; product no. A5316; Sigma) or a-tubulin antibody (1:20 000 dilution; product no. Ab7291; Abcam) to normalize the proteins. The secondary antibodies were anti-rabbit IgG-conjugated horseradish peroxidase (HRP; GE Healthcare), anti-mouse IgG-HRP (GE Healthcare), and rabbit anti-goat IgG-HRP (Santa Cruz). The protein signals were detected by chemiluminescence.
Reporter Construction, Transfection, and Dual Luciferase Reporter Assay
Complementary DNA synthesized from a human endometrial sample was used to amplify the 442-bp OLFM1 3 0 UTR and 564-bp CTBP1 3 0 UTR to study miR-212 regulation. The forward and reverse primers used for PCR amplification were synthesized by Invitrogen. The amplicons were digested with NotI (Fermentas) and XhoI (Fermentas) enzymes and purified using the GeneJet PCR Purification kit (Fermentas). The purified products were cloned downstream to the Renilla luciferase gene of the psiCHECK-2 vector (Promega) to construct the OLFM1 and the CTBP1 wild-type (WT) reporter plasmids. The miRNA recognition elements (MREs) for miR-212 in WT-OLFM1 and WT-CTBP1 were point mutated with the QuickChange II Site Directed Mutagenesis Kit (Stratagene) using the mutating primers (Supplemental Table S1 ; Supplemental Data are available online at www. biolreprod.org) synthesized by Invitrogen. The use of human endometrial sample for this study was approved by the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster (UW13-118).
HeLa cells (1 3 10 5 cells per well) grown on a 12-well tissue culture plate were cotransfected with WT reporter constructs (WT-OLFM1 and WT-CTBP1) with or without miR-212 precursor (hsa-miR-212-3p, AM17100; Applied Biosystems), miR-212 inhibitor (miRCURY LNA Inhibitor: hsa-miR-212, 410138-00; EXIQON A/S), or scramble control (miRCURY LNA Inhibitor: Negative Control A, 199004-00; EXIQON A/S) using Lipofectamine 2000 (Invitrogen). A similar set of experiments were performed with the mutated (MT) reporter constructs. The cell lysates were collected after 48 h and tested for Firefly and Renilla luciferase activities using the Dual-Luciferase Reporter Assay system (Promega). Transfections with empty vector and empty vector with scramble control were used as controls.
KOTTAWATTA ET AL. ÀDDct method was used for relative quantification of the signals. Data are presented as mean 6 SEM for independent experiments. The miR-212 expressions were analyzed using one-way ANOVA (Ishikawa, n ¼ 3; OE-E6/E7 cells, n ¼ 6). OLFM1 mRNA expressions (Ishikawa, n¼5; OE-E6/E7 cells, n¼4) and CTBP1 mRNA expressions (Ishikawa, n¼6; OE-E6/E7 cells, n¼6) were analyzed using Kruskal-Wallis (non-parametric) test. Significant differences from the hCG untreated control are denoted by *P , 0.05. In each individual experiment, RNA was extracted from 2 3 10 5 cells.
hCG MODULATES miRNA ON ENDOMETRIAL RECEPTIVITY
In Vitro Spheroid Attachment Assay
The adhesion assay with Jeg-3 spheroids was performed as previously described [32, [38] [39] [40] . Ishikawa cells were maintained in MEM and OE-E6/ E7 cells were maintained in DMEM/F12 medium. Ishikawa cells and OE-E6/E7 cells were seeded in 12-well tissue culture plates at the densities of 4 3 10 5 and 4.5 3 10 5 per well, respectively. Choriocarcinoma Jeg-3 cells with or without hCG (1, 5, and 25 IU/ml) treatment were trypsinized, and multicellular spheroids were generated as previously described [41, 42] 
Statistical Analysis
The results were analyzed using the statistical software SigmaPlot 11.0 (Systat Software Inc.). One-way ANOVA or Kruskal-Wallis test was used for multiple group comparison, and t-test or Mann-Whitney rank sum test was used for two-group comparison. A value of P , 0.05 was considered statistically significant. Each experiment was independently repeated at least three times.
RESULTS
Expression of miR-212, OLFM1, and CTBP1 in Ishikawa and OE-E6/E7 Cells
We treated Ishikawa and OE-E6/E7 cells with different concentrations of hCG for 24 h and investigated any changes in the expressions of miR-212, OLFM1, and CTBP1 mRNA and protein. Treatment with hCG (25 IU/ml) significantly upregulated the expressions of miR-212 (P , 0.05) in both cell lines (Fig. 1, A and B) . However, hCG (25 IU/ml) significantly down-regulated the expression of OLFM1 but not CTBP1 mRNA in both cell lines. The expression of miR-16 remains unchanged in all groups (Supplemental Fig. S1 ). Western blot analysis of Ishikawa and OE-E6/E7 cells treated with hCG (25 IU/ml) showed OLFM1 and CTBP1 protein expressions were significantly (P , 0.05) down-regulated (Fig. 2, A and B ).
OLFM1 and CTBP1 mRNA Contain Functional MREs for miR-212
In silico miRNA target prediction with miRanda (http:// www.microrna.org) [33] and information provided by TargetScan [43] were used to identify complementary seeding sequences for miR-212 in the 3 0 UTR regions of human OLFM1 and CTBP1 (Fig. 3A) . To confirm the role of miR-212 in regulating OLFM1 and CTBP1 expression, the 3 0 UTR of OLFM1 and CTBP1 were cloned into the psiCHECK2 vector for the dual luciferase reporter assay using HeLa cells. OLFM1 and CTBP1 proteins were also expressed in HeLa cells (Fig.  3B ). WT-OLFM1 or WT-CTBP1 reporter constructs with miR-212 precursor, miR-212 inhibitor, or scramble control were cotransfected into HeLa cells with high transfection efficiency. The miR-212 precursor significantly reduced the luciferase signal of the WT-OLFM1 and WT-CTBP1 reporters, whereas miR-212 inhibitor significantly increased the luciferase signals.
No change in the reporter signal was observed when the cells were cotransfected with the scrambled miRNA control (Fig.  3C) , or with the MT reporters MT-OLFM1 and MT-CTBP1 (Fig. 3D) .
hCG Regulates the Spheroid Attachment In Vitro
We examined the effects of hCG on embryo attachment using an in vitro spheroid attachment assay. Jeg-3 spheroids with diameters of about 100 lm were selected for the attachment assay (Fig. 4A) . Jeg-3 cells treated with hCG did not affect their rate of spheroid attachment to Ishikawa cells (Fig. 4B) , However, Ishikawa cells or OE-E6/E7 cells treated with hCG (25 IU/ml) significantly increased Jeg-3 spheroid attachment rate on monolayers of both cell lines (Fig. 4, C and  D) .
MiR-212 Regulates the OLFM1 and CTBP1 Protein Expressions in Ishikawa Cells
Ishikawa cells were treated with miR-212 precursor, inhibitor, or scramble control to study if miR-212 modulates OLFM1 and CTBP1 expression in human endometrial cells for spheroid attachment. Forced expression of miR-212 precursor significantly suppressed OLFM1 and CTBP1 protein expressions compared to cells transfected with the scramble control (Fig. 5A) , whereas the miR-212 inhibitor significantly increased OLFM1 and CTBP1 protein expressions (Fig. 5B ). There were no differences in the expressions of OLFM1 or CTBP1 in cells transfected with the vehicle (Opti-MEM and Lipofectamine 2000) or with the scramble control (Fig. 5C) .
To confirm if miR-212 modulated spheroid attachment, treated Ishikawa cells were cocultured with Jeg-3 spheroids. Treatment with miR-212 precursor significantly increased Jeg-3 spheroid attachment onto Ishikawa cells, whereas treatment with miR-212 inhibitor significantly decreased spheroid attachment compared to the controls (Fig. 5D ). There were no significant changes in the attachment rate when the Ishikawa cells were treated with scramble control or the vehicle.
DISCUSSION
The findings from this study demonstrated hCG downregulated OLFM1 and CTBP1 expression through miR-212 activation in endometrial and fallopian epithelial cells, which in turn enhanced Jeg-3 spheroid attachment.
The hormone hCG is one of the earliest blastocyst-derived signals important for the corpus luteum to maintain progesterone secretion during early pregnancy [1, 4] . The mechanism of how hCG regulates embryo implantation in eutopic and ectopic sites remains largely unknown [44] . The endometrium, the myometrium, and almost all the maternal tissues express G protein-coupled LHCGRs [45] . The LHCGRs in the endometrium are responsive to a range of hCG (1-50 IU/ml) concentrations [46] . In vitro-cultured embryos produce about 1.8 mIU hCG at Day 6 before hatching, but after hatching on Day 7, the hCG production increases up to 4 mIU. On Day 14, hCG production in the hatched blastocyst increases to around 19.5 IU, whereas hCG production in embryos trapped within zonae is only around 1.55 IU [47] . Based on hCG levels secreted from Day 5 embryos in culture medium, the levels of hCG range from 0.8-6.2 mIU/ml. In fact, the blastocyst is in very close proximity to the endometrial/fallopian surface, and the total volume of the fluid within the area is likely no more than 1-KOTTAWATTA ET AL.
2 ll. Therefore, the local hCG level could be 0.2-20 IU [48] . In this study, we found the higher hCG (25 IU/ml) concentration significantly increased the expression of miR-212 in the Ishikawa and OE-E6/E7 cells, which was consistent with the up-regulation of miR-212 in granulosa cells after injection of hCG in mice [14] .
Human chorionic gonadotropin has diverse roles in implantation, such as the regulation of cyclooxygenase 2 (COX2), leukemia inhibitory factor (LIF), vascular endothelial growth factor (VEGF), metalloprotease 9 (MMP9), and interleukin 6 (IL6) [49, 50] . However, it is not clear whether hCG regulates endometrial receptivity and implantation   FIG. 2 . Western blot analysis of OLFM1 and CTBP1 in Ishikawa and OE-E6/E7 cells treated with hCG (1, 5, and 25 IU/ml) for 24 h. Treatment with hCG (25 IU/ml) significantly suppressed OLFM1 and CTBP1 protein expressions levels in Ishikawa (n ¼ 4, one-way ANOVA) (A) and OE-E6/E7 (n ¼ 6, one-way ANOVA) (B) cells. Data were presented as mean 6 SEM for independent experiments. Significant differences are denoted by *P , 0.05. In each individual experiment, RNA was extracted from 2 3 10 5 cells.
hCG MODULATES miRNA ON ENDOMETRIAL RECEPTIVITY HeLa cells were cotransfected with WT or MT OLFM1 or CTBP1 reporter constructs with or without miR-212 precursor, miR-212 inhibitor, or scramble control for 48 h. C) WT-OLFM1 (n ¼ 3, one-way ANOVA) or WT-CTBP1 (n ¼ 4, KruskalWallis, nonparametric) reporter constructs cotransfected with miR-212 precursor significantly lowered the luciferase signal, whereas cotransfection with miR-212 inhibitor significantly increased the luciferase signal (D). The luciferase signal remained unchanged with MT-OLFM1 or MT-CTBP1 vectors (n ¼ 3, one-way ANOVA). Data are presented as mean 6 SEM for independent experiments. Significant differences between groups are denoted by *P , 0.05 and **P , 0.001. through miRNA expression. In fact, miRNAs are important in normal embryo development, implantation, placental formation, and pregnancy [13] . For example, miR-494 and miR-923 are down-regulated during the midsecretory phase of the menstrual cycle in women [51, 52] . Also, it is reported that a higher Lin28B/Let-7a ratio in ectopic embryonic tissues at 6 wk gestation [53] . Down-regulation of hsa-mir-196 but up-regulation of hsa-mir-223 and hsa-mir-451 have been found in ectopic embryonic tissues when compared to the embryonic tissues from control abortions [54] . A recent study suggests serum miR-323-3p could act as a marker to diagnose ectopic pregnancies with 37% sensitivity and 90% specificity [55] . Combined detection of miR-323-3p, hCG, and progesterone could achieve 96.3% sensitivity and 72.6% specificity [55] . Another recent study reports that miR-212 regulates early embryogenesis during the maternal to zygotic transition in bovine embryos [18] . In addition, hCG has been found to regulate the expression of miR-212 involved in the mediation of cAMP/CREB signaling in granulosa cells in mice [56] .
In the cell cytoplasm, mature miRNA binds to RNAinduced silencing complex to form the miRNA-induced silencing complex (miRISC) that can then bind to the target mRNAs to regulate protein synthesis [57] . The mature miRNA within the miRISC binds to the 2-8 nucleotides of the 3 0 UTR in the target mRNA [43] regulating posttranscriptional gene expressions in the cytoplasm [58] . In this study, using in silico miRNA prediction, we found the 3 0 UTR of OLFM1 and CTBP1 contained sequences complementary to the seeding sequences of miR-212. We demonstrated miR-212 downregulated OLFM1 and CTBP1 protein expressions in Ishikawa and OE-E6/E7 cells. However, miR-212 down-regulated the level of OLFM1 but not CTBP1 mRNA, suggesting the regulation of CTBP1 expression was at the translational level.
FIG. 4.
Spheroid attachment on hCG-treated Ishikawa and OE-E6/E7 cells. A) Spheroids (;100 lm in diameter) were used as a blastocyst surrogate for the in vitro attachment assay. The attachment rate was calculated as the percentage of attached spheroids to the total number of spheroids added. B) Jeg-3 cells treated with hCG had no effect on spheroid attachment rate (n ¼ 6, one-way ANOVA). C, D) Ishikawa cells (n ¼ 4, one-way ANOVA; C) and OE-E6/E7 cells (n ¼ 5, one-way ANOVA; D) treated with hCG (25 IU/ml) for 24 h significantly increased attachment rate compared to untreated controls. In each individual experiment, around 20-30 spheroids were added for attachment assay. Data are presented as mean 6 SEM for independent experiments. Significant differences from untreated hCG control are denoted by *P , 0.05. Consistent with our data, results from other laboratories have demonstrated that miR-132/-212 decreased Ctbp1 protein level but not mRNA level in mouse granulosa cells [14] . Forced expression of miR-212 precursor suppressed OLFM1 and CTBP1 expressions but increased spheroid attachment rate, whereas forced expression of miR-212 inhibitor induced OLFM1 and CTBP1 expressions but decreased spheroid attachment rate.
OLFM1 expression has been found to be down-regulated during the WOI in human endometrium [32] . Olfactomedin 1 to OLFM4 mRNA is highly expressed in human fallopian tubes at the follicular phase of the cycle. OLFM1 expression has also been found to be down-regulated in fallopian tubes in patients with tubal ectopic pregnancies [34] . In addition, OLFM1 expression is higher in patients with unexplained recurrent spontaneous abortion compared to normal fertile women [59] . The embryo-derived hCG may suppress OLFM1 expression at eutopic or ectopic sites during embryo implantation.
Choriocarcinoma Jeg-3 cells can express hCG, human chorionic somatomammotropin (placental lactogen), and progesterone [60] . We used Jeg-3 spheroids as embryo surrogates to study the role of hCG and miR-212 on implantation. In our coculture assay, the spheroid attachment rate on Ishikawa and OE-E6/E7 cells increased significantly when Ishikawa and OE-E6/E7 cells but not Jeg-3 cells were treated with hCG (25 IU/ ml). However, there was no difference in the spheroid attachment rate when Jeg-3 cells but not Ishikawa cells were treated with hCG. The results suggest that embryo-derived hCG could interact with maternal tissues (endometrial and fallopian tube epithelial cells) modulating the maternal environment to favor embryo implantation. Previously, we reported the activation of Wnt-signaling pathway by Wnt3a-conditioned medium or lithium chloride in OE-E6/E7 cells down-regulated OLFM1 expression and increased JAr spheroid attachment [34] . The Wnt-signaling antagonist dickkopf homolog 1 (DKK1) suppressed JAr spheroid attachment onto Ishikawa monolayers [34] . Furthermore, hCG is a known regulator of Wnt ligands in mouse mammary tumors [61] ; whether hCG directly regulates Wnt-signaling pathway in the fallopian tubal and endometrial epithelial cells remains to be investigated.
In summary, our results demonstrated hCG stimulated miR-212 expression in the human endometrial and fallopian epithelial cells. The binding of miR-212 to the 3 0 UTR of OLFM1 and CTBP1 gene then down-regulated OLFM1 and CTBP1 expressions to enhance spheroid attachment. The findings from this study further suggest that the embryo retained in the fallopian tube may produce a high local hCG level that down-regulates OLFM1 and CTBP1 expressions, leading to tubal ectopic pregnancy. However, further investigations are needed to determine whether hCG directly regulates OLFM1 and CTBP1 expression independently of miR-212. The use of human primary tissues (endometrial and fallopian tube) and animal models may further confirm the role of hCG and miRNA on embryo implantation. As the human endometrium and fallopian tube are under the influence of steroid hormones, the combined effect of steroid hormones and hCG on miR-212 expression remains unclear and warrants further investigation.
